THERAPEUTICALLY RESISTANT ASTHMA
- Authors: Trofimov V.1, Mironova Z.1
-
Affiliations:
- Acad. I.P. Pavlov Saint Petersburg State Medical University
- Issue: Vol 23, No 3 (2012)
- Pages: 2
- Section: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115298
- ID: 115298
Cite item
Open Access
Access granted
Abstract
Therapy resistant asthma (TRA) is most difficult to treat and its course is least predictable. TRA remains least studied notwithstanding the fact that its many mechanisms have been detected. To this point there has been no clear definition of TRA and this terminology has not been widely used so far. This paper gives the results of an investigation, which could identify the phenotype of TRA, by taking into account its pathogenetic and clinical heterogeneity, reveal the predictors of the disease, and elaborate unique criteria to make its diagnosis.
Full Text
About the authors
V. Trofimov
Acad. I.P. Pavlov Saint Petersburg State Medical University
Email: trofvi@mail.ru
Zh. Mironova
Acad. I.P. Pavlov Saint Petersburg State Medical University
References
- Gibeon, D., Campbell D., Debbie A. et al. The Systematic Assessment of Difficult-to-Treat Asthma: Why Do It? // Clinical Pulmonary Medicine. - 2010; 17 (6): 255-259.
- Федосеев Г.Б., Трофимов В.И., Петрова М. А. Многоликая бронхиальная астма, диагностика, лечение и профилактика. - М.: Нордмедиздат, 2011. - С. 343.
- Wenzel S. Severe Asthma in Adults // Am. J. Respir. Crit. Care Med. - 2005; 172: 149-160.
- Proceeding of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society // Am. J. Respir. Crit. Care Med.- 2000; 162: 2341-2351.
- Global Initiative for Asthma. Global strategy for asthma management and prevention. Workshop Report (электронный ресурс), 2008. Доступ: http://www. Ginaasthma.com.
- Ito K., Chung K., Adcock I. Update on glucocortucoid action and resistance // J. Allergy Clin. Immunol. - 2006; 3: 522-543.
- Newton R., Leigh R., Giembycz M. Pharmacological strategies for improving the efficacy and therapeutic ratio of glucocorticoids in inflammatory lung disease // Pharmacology & Therapeutics. - 2010; 125: 286-327.
- Трофимов В.И. Руководство по диагностике, лечению и профилактике бронхиальной астмы / под ред. А. Г. Чучалина. - М., 2005.
- Miller М., Lee J., Blanc P. et al. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma // Eur. Respir. J. - 2006; 28: 1145-1155.
- Mason R., Broaddus V., Martin T. et al. Murray & Nadel, s/Textbook of Respiratory medicine 5th edition V.1 Elsevier., 2010. - P. 883-918.
- Федосеев Г.Б., Трофимов В.И., Рогачева H.H. и др. Роль нейтрофилов и бактериальной инфекции респираторного тракта у больных бронхиальной астмой и хронической обструктивной болезнью легких // Росс. аллергологический журн. - 2011; 2: 34-43.
- Петровский В.Ф., Огородова Л.М. Выбор фармакотерапии тяжелой Б.А. // Пульмонология. - 2008; 3: 84-89.
Supplementary files
